(CLVT) CLARIVATE - Ratings and Ratios

Clarivate Plc (NYSE:CLVT) is a global leader in providing mission-critical information services and specialized expertise to academia, governments, life sciences, healthcare, and intellectual property sectors. The company operates through three core segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. Clarivates solutions are designed to empower research institutions, corporations, and professionals to make informed decisions across the entire innovation lifecycle.

The companys portfolio includes ProQuest One, a multidisciplinary research platform offering access to databases, dissertations, news, primary sources, books, and video content. Alma, Polari, and Vega provide libraries with a unified platform to manage resources and unique materials effectively. In the intellectual property space, IPFolio and FoundationIP enable companies to secure, manage, and protect their IP assets through advanced automation, data analytics, and expertise. Derwent Innovation and CompuMark solutions cater to patent and trademark professionals, offering tools for patentability, freedom-to-operate, and validity decisions. Cortellis, a suite of life sciences products, supports drug development decisions across the entire lifecycle.

Clarivate serves a diverse client base, including research institutions, universities, law firms, government agencies, and corporations. The company, formerly known as Clarivate Analytics Plc, rebranded in May 2020 and traces its roots back to 1864. Headquartered in London, Clarivate operates globally, with a strong presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its website is accessible at https://www.clarivate.com.

Based on the provided data, here is a 3-month forecast:

- Ticker Symbol: CLVT - Exchange: NYSE - Type: Common Stock - Country Origin: United Kingdom - GICS Sub Industry: Research & Consulting Services - Average Volume 20d: 5,929,496 - Last Price: 4.21 - SMA 20: 3.51 - SMA 50: 3.98 - SMA 200: 5.43 - ATR: 0.26

- Market Cap: $2,370.01M USD - P/E: None - P/E Forward: 5.27 - P/B: 0.47 - P/S: 0.93 - RoE: -12.39

3-Month Forecast: - Price Target: $4.50 - $5.00 - Technical Outlook: The stock has recently broken above its SMA50 and SMA20, indicating short-term bullish momentum. However, the SMA200 at 5.43 may act as resistance. - Volatility: ATR of 0.26 suggests moderate price movement. - Fundamental Outlook: The forward P/E of 5.27 indicates market expectations for earnings growth, but the negative RoE of -12.39 raises concerns about profitability. - Risks: The stock may face headwinds if the company fails to improve its return on equity or meet growth expectations.